Study Looks at Effects of Reducing Intake of Processed Meat, Unprocessed Red Meat
By Elana Gotkine HealthDay Reporter
MONDAY, July 29, 2024 -- Reductions in processed meat and unprocessed red meat consumption could result in fewer occurrences of type 2 diabetes, cardiovascular disease, colorectal cancer, and all-cause deaths, according to a study published in the July issue of The Lancet Planetary Health.
Joe Kennedy, Ph.D., from the University of Edinburgh in the United Kingdom, and colleagues developed a microsimulation model to estimate how reductions in processed meat and unprocessed red meat could affect the rates of type 2 diabetes, cardiovascular disease, colorectal cancer, and mortality in U.S. adults. A total of 8,665 individual respondents were included in the simulated population, representing 242 million U.S. adults.
The researchers estimated that a reduction of 30 percent in processed meat intake alone could result in 352,900; 92,500; and 53,300 fewer occurrences of type 2 diabetes, cardiovascular disease, and colorectal cancer, respectively, and 16,700 fewer all-cause deaths during a 10-year period. A 30 percent reduction in unprocessed red meat intake alone could lead to 732,600; 291,500; and 32,200 fewer occurrences of type 2 diabetes, cardiovascular disease, and colorectal cancer, respectively, and 46,100 fewer all-cause deaths. A 30 percent reduction in both processed meat and unprocessed red meat intake could result in 1,073,400; 382,400; and 84,400 fewer occurrences of type 2 diabetes, cardiovascular disease, and colorectal cancer, respectively, and 62,200 fewer all-cause deaths during a 10-year period.
"Although the USA has not yet adopted a meat-reduction target and no policies are currently in place with the explicit aim of reducing meat intake, many national and international organizations have called for such reductions," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study...
DDW: Systematic Program Increases Likelihood of Up-to-Date Colorectal Cancer Screening
FRIDAY, April 25, 2025 -- A systematic program of monitoring colorectal cancer (CRC) screening status increases up-to-date screening status, according to a study presented at the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.